Eisai, Inc., a U.S. subsidiary of Eisai Co., Ltd., plans to restructure its operations, cutting approximately 20% of its workforce across all U.S. functions, resulting in the loss of 600 positions by April 1, 2011. The restructuring is part of Eisai’s global strategic plan for FY2011-2015, to become a more efficient and focused organization. The company plans to focus on advancing its oncology portfolio and launch new neuroscience assets. Eisai’s U.S. operations include R&D, manufacturin...